Boston, Massachusetts | August 2021
Clear Scientific’s Chief Scientific Officer, Mitchell Zakin PhD, Executive VP Chemistry, Xinhua Li PhD, and Medical Director, John Marota MD, PhD, presented progress on CS-1103, a first-in-class therapeutic for treatment of acute methamphetamine intoxication, at the 6th Annual Chemistry and Pharmacology of Drug Abuse Conference (CPDA). This event, held in Boston, MA on August 6th and 7th, 2021, brings together leading medicinal chemists, pharmacologists, and clinicians to present their recent findings on treatment of substance-abuse disorder. In nonclinical studies, CS-1103 has been shown to be well tolerated and efficacious against high levels of methamphetamine.